Douglas C. Lane & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Douglas C. Lane & Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$54.8M	Sell	386,565 -5,460	-1%	-$728K	1.48%	18
2015 Q3	$47.9M	Buy	392,025 +4,686	+1%	+$611K	1.36%	24
2015 Q2	$50.3M	Buy	387,339 +12,081	+3%	+$1.57M	1.35%	22
2015 Q1	$50.4M	Buy	375,258 +261	+0.1%	+$33.6K	1.32%	22
2014 Q4	$47M	Buy	374,997 +9,340	+3%	+$1.14M	1.27%	23
2014 Q3	$44.5M	Buy	365,657 +18,619	+5%	+$2.26M	1.33%	22
2014 Q2	$41M	Sell	347,038 -5,471	-2%	-$644K	1.24%	27
2014 Q1	$42.4M	Sell	352,509 -6,650	-2%	-$791K	1.36%	21
2013 Q4	$40M	Sell	359,159 -4,361	-1%	-$434K	1.33%	24
2013 Q3	$33.5M	Sell	363,520 -594	-0.2%	-$53.7K	1.22%	31
2013 Q2	$30.8M	Buy	+364,114	New	+$30.3M	1.2%	31

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Douglas C. Lane & Associates's TMO Position: Q4 2015 in Review

Douglas C. Lane & Associates reduced its Thermo Fisher Scientific (TMO) stake by 1.4% in Q4 2015, selling an estimated $728K and leaving 386,565 shares worth $54.8M. The position accounts for 1.48% of the portfolio, ranked #18.

Douglas C. Lane & Associates first reported a position in TMO in Q2 2013 and has held it in 11 quarters since. 1,007 funds tracked by Wall St. Rank hold TMO as of Q4 2015.

Douglas C. Lane & Associates held 386,565 shares of Thermo Fisher Scientific worth $54.8M as of Q4 2015.
Douglas C. Lane & Associates sold 5,460 Thermo Fisher Scientific shares in Q4 2015, an estimated $728K.
Thermo Fisher Scientific made up 1.48% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #18 holding.
Douglas C. Lane & Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 11 quarters since.
1,007 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.